- Telehealth Visits
- Insurance plan information
Robert Sperling, MD
- Telehealth Visits
- Insurance plan information
Robert Sperling, MD
- Telehealth Visits
- Insurance plan information
On this page
About me
Education & training
Board certification
- Interventional Cardiology, American Board of Internal Medicine
- Cardiovascular Disease, American Board of Internal Medicine
Fellowship
- Interventional Cardiology, Beth Israel Deaconess Medical Center GME
- Vascular Medicine, St Elizabeths Medical Center/Boston Medical Center
- Cardiovascular Disease, Beth Israel Deaconess Medical Center GME
Residency
- Internal Medicine, Brigham and Womens Hospital GME
Internship
- Internal Medicine, Brigham and Womens Hospital GME
Degree
- MD, Duke University School of Medicine
Component Name: Provider Research Listing component built but no clinical trials or publications to display
Clinical Trials query: q=health_gateway_id_ss%3A%28%22938%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%22938%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.